110.88
price up icon0.10%   0.11
after-market アフターアワーズ: 110.16 -0.72 -0.65%
loading
前日終値:
$110.77
開ける:
$110.75
24時間の取引高:
401.20K
Relative Volume:
0.48
時価総額:
$26.66B
収益:
$3.13B
当期純損益:
$-381.72M
株価収益率:
-69.12
EPS:
-1.6042
ネットキャッシュフロー:
$-2.15B
1週間 パフォーマンス:
-2.33%
1か月 パフォーマンス:
-0.50%
6か月 パフォーマンス:
-7.61%
1年 パフォーマンス:
+27.11%
1日の値動き範囲:
Value
$110.62
$112.90
1週間の範囲:
Value
$109.28
$114.15
52週間の値動き範囲:
Value
$81.20
$131.49

Biontech Se Adr Stock (BNTX) Company Profile

Name
名前
Biontech Se Adr
Name
セクター
Healthcare (1157)
Name
電話
-
Name
住所
-
Name
職員
6,772
Name
Twitter
@BioNTech_Group
Name
次回の収益日
2025-03-10
Name
最新のSEC提出書
Name
BNTX's Discussions on Twitter

BNTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BNTX
Biontech Se Adr
110.88 27.06B 3.13B -381.72M -2.15B -1.6042
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-05 繰り返されました H.C. Wainwright Buy
2025-05-29 開始されました Goldman Neutral
2025-03-13 開始されました Citigroup Buy
2025-01-10 開始されました Truist Buy
2024-12-11 開始されました Wells Fargo Overweight
2024-12-02 繰り返されました BMO Capital Markets Outperform
2024-11-19 開始されました Berenberg Buy
2024-11-19 アップグレード Evercore ISI In-line → Outperform
2024-11-08 アップグレード Goldman Neutral → Buy
2024-09-24 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-09-17 アップグレード Jefferies Hold → Buy
2024-09-16 アップグレード JP Morgan Underweight → Neutral
2024-08-07 アップグレード Deutsche Bank Hold → Buy
2024-08-02 アップグレード HSBC Securities Hold → Buy
2024-05-14 開始されました Evercore ISI In-line
2024-02-23 開始されました BMO Capital Markets Outperform
2024-01-05 開始されました Oppenheimer Perform
2023-12-01 ダウングレード JP Morgan Neutral → Underweight
2023-10-16 ダウングレード HSBC Securities Buy → Hold
2023-07-14 開始されました HSBC Securities Buy
2023-05-17 アップグレード Redburn Neutral → Buy
2022-12-15 アップグレード BofA Securities Neutral → Buy
2022-08-17 開始されました Cowen Market Perform
2022-07-13 アップグレード SVB Leerink Mkt Perform → Outperform
2022-07-06 再開されました Canaccord Genuity Buy
2022-02-01 アップグレード Redburn Sell → Neutral
2021-12-16 開始されました Morgan Stanley Equal-Weight
2021-11-10 アップグレード H.C. Wainwright Neutral → Buy
2021-10-22 開始されました Deutsche Bank Hold
2021-10-07 開始されました Jefferies Hold
2021-08-11 アップグレード Bryan Garnier Neutral → Buy
2021-07-19 再開されました Wolfe Research Outperform
2021-06-16 ダウングレード Redburn Neutral → Sell
2021-05-18 開始されました Goldman Neutral
2021-05-11 ダウングレード Bryan Garnier Buy → Neutral
2020-12-01 ダウングレード BofA Securities Buy → Neutral
2020-08-03 再開されました Berenberg Buy
2020-07-21 アップグレード BofA Securities Neutral → Buy
2020-06-30 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-19 アップグレード H.C. Wainwright Neutral → Buy
2020-04-28 ダウングレード BofA/Merrill Buy → Neutral
2020-03-18 ダウングレード JP Morgan Overweight → Neutral
2020-03-09 開始されました H.C. Wainwright Neutral
2020-01-24 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-01-22 ダウングレード UBS Buy → Neutral
2019-11-05 開始されました Wolfe Research Outperform
2019-11-04 開始されました Berenberg Buy
2019-11-04 開始されました BofA/Merrill Buy
2019-11-04 開始されました Canaccord Genuity Buy
2019-11-04 開始されました JP Morgan Overweight
2019-11-04 開始されました SVB Leerink Outperform
2019-11-04 開始されました UBS Buy
すべてを表示

Biontech Se Adr (BNTX) 最新ニュース

pulisher
Aug 20, 2025

BioNTech’s BNT327 Clinical Trial: A New Hope for Small-Cell Lung Cancer? - MSN

Aug 20, 2025
pulisher
Aug 18, 2025

Pfizer and BioNTech’s Combined Vaccine Study: A Potential Game-Changer - TipRanks

Aug 18, 2025
pulisher
Aug 18, 2025

BioNTech ADR Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

Aug 18, 2025
pulisher
Aug 18, 2025

HC Wainwright Has Bearish Estimate for BioNTech Q3 Earnings - Defense World

Aug 18, 2025
pulisher
Aug 16, 2025

US Bancorp DE Cuts Stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX) - Defense World

Aug 16, 2025
pulisher
Aug 15, 2025

BioNTech (NASDAQ:BNTX) Price Target Lowered to $136.00 at HC Wainwright - Defense World

Aug 15, 2025
pulisher
Aug 14, 2025

BioNTech’s BNT113 Trial: A Potential Game-Changer in Head and Neck Cancer Treatment - TipRanks

Aug 14, 2025
pulisher
Aug 13, 2025

BioNTech’s BNT327 Trial: A New Hope for Small-cell Lung Cancer? - TipRanks

Aug 13, 2025
pulisher
Aug 12, 2025

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency - Benzinga

Aug 12, 2025
pulisher
Aug 12, 2025

BioNTech’s Promising Lung Cancer Study: A Potential Game-Changer in Oncology - TipRanks

Aug 12, 2025
pulisher
Aug 09, 2025

BioNTech’s BNT327 Study: A New Hope for Lung Cancer Treatment? - The Globe and Mail

Aug 09, 2025
pulisher
Aug 08, 2025

BioNTech’s Promising Phase II Study on BNT327 for Small-cell Lung Cancer - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

Genmab and BioNTech’s Innovative Cancer Trial: A Market Game Changer? - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

BioNTech and Genmab’s Promising Colorectal Cancer Study: A Potential Game-Changer? - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

BioNTech SE’s BNT331 Safety Trial: A Potential Game-Changer in Women’s Health - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Genmab and BioNTech’s Promising Cancer Study: A Potential Game-Changer? - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Pfizer and BioNTech’s New Shingles Vaccine Study: A Potential Game-Changer? - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Genmab and BioNTech’s GEN1042 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

BioNTech’s BNT327 Study: A New Hope for Advanced Lung Cancer Treatment - TipRanks

Aug 07, 2025
pulisher
Aug 06, 2025

BioNTech ADR Earns RS Rating Upgrade - Investor's Business Daily

Aug 06, 2025
pulisher
Aug 06, 2025

BioNTech’s Strategic Moves and Financial Outlook - The Globe and Mail

Aug 06, 2025
pulisher
Aug 05, 2025

BioNTech SE Earnings Call: Strategic Growth Amid Challenges - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Genmab and BioNTech SE’s GEN1056 Study: A New Hope for Advanced Solid Tumors - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

BioNTech Earnings: Guidance Reiterated; Incremental Progress in Clinical Trials - Morningstar

Aug 05, 2025
pulisher
Aug 05, 2025

Kylian Mbappe fires out strong message after taking iconic No. 10 shirt at Real Madrid - Goal.com

Aug 05, 2025
pulisher
Aug 04, 2025

BioNTech ADR Earns Relative Strength Rating Upgrade - MSN

Aug 04, 2025
pulisher
Aug 04, 2025

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update04.08.25News - Ariva

Aug 04, 2025
pulisher
Aug 04, 2025

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Aug 04, 2025
pulisher
Aug 02, 2025

BioNTech’s BNT327: A Promising New Approach in Breast Cancer Treatment - The Globe and Mail

Aug 02, 2025
pulisher
Aug 02, 2025

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday - Defense World

Aug 02, 2025
pulisher
Jul 30, 2025

BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - GlobeNewswire Inc.

Jul 30, 2025
pulisher
Jul 29, 2025

Best Momentum Stocks to Buy for July 29th - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

New Strong Buy Stocks for July 29th - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Shares Acquired by Kestra Private Wealth Services LLC - Defense World

Jul 29, 2025
pulisher
Jul 27, 2025

Cerity Partners LLC Invests $357,000 in BioNTech SE Sponsored ADR (NASDAQ:BNTX) - Defense World

Jul 27, 2025
pulisher
Jul 25, 2025

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union - Ariva

Jul 25, 2025
pulisher
Jul 24, 2025

BioNTech’s Promising Study on Pancreatic Cancer Treatment: Market Implications - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Genmab and BioNTech Launch Promising Study for Advanced Colorectal Cancer Treatment - TipRanks

Jul 23, 2025
pulisher
Jul 22, 2025

BioNTech’s New Study on PDAC Treatment: Key Insights for Investors - TipRanks

Jul 22, 2025
pulisher
Jul 18, 2025

Pfizer and BioNTech’s New Shingles Vaccine Study: What Investors Need to Know - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

BioNTech’s BNT327 Trial: A Potential Game-Changer in Lung Cancer Treatment? - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Swansea Building Society Extends Support for Swansea City AFC - Business News Wales

Jul 18, 2025
pulisher
Jul 17, 2025

BioNTech’s Promising Lung Cancer Trial: A Potential Game-Changer for NSCLC Treatment - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

BioNTech Announces Ryan Richardson to Step Down from the Management Board17.07.25News - Ariva

Jul 17, 2025
pulisher
Jul 16, 2025

BioNTech’s DYNASTY-Breast02 Study: A New Hope for Metastatic Breast Cancer? - TipRanks

Jul 16, 2025
pulisher
Jul 13, 2025

OneDigital Investment Advisors LLC Makes New Investment in BioNTech SE Sponsored ADR (NASDAQ:BNTX) - Defense World

Jul 13, 2025

Biontech Se Adr (BNTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$131.88
price down icon 0.54%
$26.20
price up icon 0.73%
biotechnology ONC
$313.67
price down icon 0.10%
$85.04
price down icon 1.72%
$24.65
price up icon 0.94%
大文字化:     |  ボリューム (24 時間):